Key result
Only ~57% of hypertensive Prolanis participants maintain routine adherence to antihypertensive medication.
Why the study?
Successful hypertension control requires adherence to antihypertensive medication, and this study aimed to describe medication adherence among hypertensive patients participating in the Chronic Disease Management Program (Prolanis) in four villages in Turen District.
Cross-Sectional (n=61)
Yes
Although 57.4% of hypertensive patients in the rural Indonesian Prolanis chronic disease program routinely took antihypertensive medication, 42.6% were either non-adherent or not taking medication, highlighting the need for continuous education and monitoring in primary care.
Answers are grounded in this paper and cite their sources.
Non-adherence affects over 40% of Prolanis participants; hypothesis-generating for targeted adherence interventions in community hypertension programs.
Hypertension is one of the most common non-communicable diseases and a major risk factor for cardiovascular diseases. Successful hypertension control depends not only on the availability of healthcare services but also on patients' adherence to antihypertensive medication. The Chronic Disease Management Program (Program Pengelolaan Penyakit Kronis/Prolanis) was developed to improve the quality of healthcare services and enhance patients' adherence to long-term treatment. This study aimed to describe medication adherence among hypertensive patients participating in the Chronic Disease Management Program (Prolanis) in Sanankerto, Kedok, Jeru, and Sananrejo Villages, Turen District. This study employed a descriptive quantitative research design. Data were collected during Prolanis activities through interviews using a Google Form administered to participants undergoing health examinations in four villages within the working area of UPT Puskesmas Turen. The variables collected included age, sex, disease status, and medication adherence. The study sample consisted of 61 Prolanis participants diagnosed with hypertension or hypertension accompanied by diabetes mellitus. Data were analyzed descriptively and presented as frequency distribution tables and percentages. The results showed that most respondents were aged 60–69 years (47.5%), female (93.4%), and diagnosed with hypertension without diabetes mellitus (67.2%). Regarding medication adherence, 35 respondents (57.4%) routinely took antihypertensive medication, 14 respondents (23.0%) were not adherent, and 12 respondents (19.7%) did not take antihypertensive medication. Most hypertensive Prolanis participants in Sanankerto, Kedok, Jeru, and Sananrejo Villages routinely took antihypertensive medication. However, a considerable proportion of participants were either non-adherent or did not take medication at all. Therefore, continuous education, regular monitoring, and patient support through the Prolanis program are needed to improve medication adherence and support optimal hypertension control.
No takes yet. Share an insight, caveat, or question.
Saputra et al. (2026) conducted a cross-sectional in Hypertension (with or without diabetes mellitus) (n=61). Chronic Disease Management Program (Prolanis) participation and antihypertensive medication was evaluated on Routine adherence to antihypertensive medication. Among 61 hypertensive Prolanis participants in Turen District, 57.4% routinely took antihypertensive medication, while 23.0% were non-adherent and 19.7% took no medication.
Synapse has enriched 10 related papers. Consider them for comparative context: